Detailed Information for S00059

Basic information about inhibitors

IPAD-DB ID S00059
Name N-(1-Benzylpyrrolidin-3-yl)-2-(3-phenylpiperidin-1-yl)acetamide
Category Synthetic compounds
2D Structure
3D Structure
Molecular Formula C 2 4 H 3 1 N 3 O
Molecular Weight 377.5 g/mol
IUPAC Name N-(1-benzylpyrrolidin-3-yl)-2-(3-phenylpiperidin-1-yl)acetamide
InChI InChI=1S/C24H31N3O/c28-24(19-26-14-7-12-22(17-26)21-10-5-2-6-11-21)25-23-13-15-27(18-23)16-20-8-3-1-4-9-20/h1-6, 8-11, 22-23H, 7, 12-19H2, (H, 25, 28)
InChIKey LJIUZOIBJFVUCF-UHFFFAOYSA-N
Canonical SMILES C1CC(CN(C1)CC(=O)NC2CCN(C2)CC3=CC=CC=C3)C4=CC=CC=C4
PubChem CID 155547047
DrugBank Accession Number -
CAS Registry Number -

Biological activity data

Ki -
EC50
IC50
Inhibition 30.6% ± 1.6(eeAChE%), 46.0% ± 0.7(eqBCHE%), 14.7% ± 6.9(hBACE1%), 38.8% ± 4.6(In cellulo Aβ42 inhibition %), 43.6% ± 1.3(In cellulo tau inhibition %),
Toxicity
ROS(reactive oxygen species)
Metal Chelating
BBB(blood-brain barrier)
Target Protein Aβ1-42
Effects
Research Models Escherichia coli, molecular docking , in vitro, in Bacterial Cells,
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME) 377.52
Hac(Computed by SwissADME) 28
Volume(Computed by ADMETlab 2.0) 412.76
Density(Computed by ADMETlab 2.0) 0.914
nRing(Computed by ADMETlab 2.0) 4
MaxRing(Computed by ADMETlab 2.0) 6
nHet(Computed by ADMETlab 2.0) 4
fChar(Computed by ADMETlab 2.0) 0
nRig(Computed by ADMETlab 2.0) 24
Flexibility(Computed by ADMETlab 2.0) 0.292
Stero Centers(Computed by ADMETlab 2.0) 2
LogS(Computed by ADMETlab 2.0) -2.297
LogD(Computed by ADMETlab 2.0) 3.363

ADMET properties

logP(Computed by ADMETlab 2.0) 3.686
TPSA(Computed by SwissADME) 35.58
Hbond Acceptor(Computed by SwissADME) 3
Hbond Donor(Computed by SwissADME) 1
Rotatable Bonds(Computed by SwissADME) 7

Pharmacokinetics

GI Absorption(Computed by SwissADME) High
BBB(blood-brain barrier) Permeant(Computed by SwissADME) Yes
P-gp Substrate(Computed by SwissADME) Yes
CYP1A2 Inhibitor(Computed by SwissADME) No
CYP2C19 Inhibitor(Computed by SwissADME) No
CYP2C9 Inhibitor(Computed by SwissADME) No
CYP2D6 Inhibitor(Computed by SwissADME) Yes
CYP3A4 Inhibitor(Computed by SwissADME) Yes
log Kp(Skin Permeation)(Computed by SwissADME) -6.07

Druglikeness

Lipinski(Computed by SwissADME) 0
Ghose(Computed by SwissADME) 0
Veber(Computed by SwissADME) 0
Egan(Computed by SwissADME) 0
Muegge(Computed by SwissADME) 0
Bioavailability Score(Computed by SwissADME) 0.55